98 related articles for article (PubMed ID: 3323042)
1. Lymphocyte surface markers profile in acute lymphoblastic leukaemia.
Mehta MM; Contractor NM; Gopal R; Advani SH; Thiel E; Thierfelder S; Bhatia HM
Indian J Med Res; 1987 Sep; 86():329-34. PubMed ID: 3323042
[No Abstract] [Full Text] [Related]
2. Definition of the high-risk acute lymphoblastic leukemia patient by immunological phenotyping with monoclonal antibodies.
Zipf TF; Fox RI; Dilley J; Levy R
Cancer Res; 1981 Nov; 41(11 Pt 2):4786-9. PubMed ID: 6975160
[TBL] [Abstract][Full Text] [Related]
3. [Abnormal phenotype of a chronic lymphatic leukemia: presence of T and B markers defined by monoclonal antibodies].
Gómez Morales M; De Andrés MA; Garrido ML; Delgado C; Cabrera A; Garrido F
Sangre (Barc); 1985; 30(3):348-54. PubMed ID: 3929410
[No Abstract] [Full Text] [Related]
4. [Surface membrane receptors, differentiation antigens and cytochemical characteristics of blood cells in acute lymphoblastic leukemia in children].
Gluzman DF; Skliarenko LM; Nadgornaia VA; Poludnenko LIu; Sidorenko SP
Eksp Onkol; 1987; 9(3):36-9. PubMed ID: 2956083
[TBL] [Abstract][Full Text] [Related]
5. [Clinical investigation of two cases with acute lymphoblastic leukemia (FAB L2) showing monoclonal antigens associated with myelomonocyte].
Nonoyama S; Minakuti J; Takase K; Takagi S; Okawa H; Yata J; Dan K
Rinsho Ketsueki; 1986 Jun; 27(6):860-5. PubMed ID: 3463805
[No Abstract] [Full Text] [Related]
6. [Immunobiological features of acute lymphoblastic leukaemia].
Gavosto F
Haematologica; 1983; 68(1):1-19. PubMed ID: 6404699
[No Abstract] [Full Text] [Related]
7. [Acute lymphocytic leukemia--immunological classification and prognosis].
Chen P; Ho C; Hwang T; Ogasawara M; Kikuchi K
Rinsho Ketsueki; 1982 Oct; 23(10):1555-60. PubMed ID: 6961243
[No Abstract] [Full Text] [Related]
8. Immunological and molecular classification of acute lymphoblastic leukemia.
Foa R; Migone N; Gavosto F
Haematologica; 1986; 71(4):277-85. PubMed ID: 3096821
[No Abstract] [Full Text] [Related]
9. Surface phenotype and clinical stages in B-cell chronic lymphocytic leukaemia.
Orfao A; Gonzalez M; San Miguel JF; Moro MJ; Fernandez-Calvo J; Carnero M; Galindo P; Lopez Borrasca A
Haematologica; 1987; 72(1):39-43. PubMed ID: 3108093
[No Abstract] [Full Text] [Related]
10. [Acute lymphoblastic leukemia in children. The use of antisera specific for lymphocyte populations in a classification trial].
Andary M; Clot J; Brochier J; Levallois C; Dossa D; Marguerite G; Jean R
Arch Fr Pediatr; 1979; 36(8):751-9. PubMed ID: 317241
[TBL] [Abstract][Full Text] [Related]
11. Cell markers and acute leukaemia subtypes in Chile.
Cabrera ME; Inostroza J; Paèz E; Monsalve V; Zapata C; Pesse F
Leuk Res; 1985; 9(6):809-12. PubMed ID: 3859723
[TBL] [Abstract][Full Text] [Related]
12. Immunological classification of adult lymphocytic leukemia based on the conventional cell markers and monoclonal antibody-defined cell surface antigens.
Kawashima K; Nagura E; Ogura M; Murase T; Morishita Y; Ohno R; Kato Y; Yokomaku S; Mizuno S; Takeyama H
Nihon Ketsueki Gakkai Zasshi; 1985 Jul; 48(4):1017-29. PubMed ID: 3864322
[No Abstract] [Full Text] [Related]
13. Reactivity of acute lymphoblastic leukemia and normal bone marrow cells with the monoclonal anti-B-lymphocyte antibody, anti-Y 29/55.
Hirt A; Baumgartner C; Forster HK; Imbach P; Wagner HP
Cancer Res; 1983 Sep; 43(9):4483-5. PubMed ID: 6603266
[TBL] [Abstract][Full Text] [Related]
14. [Surface marker analysis with monoclonal antibodies in childhood acute lymphocytic leukemia].
Kawai S; Fujimoto T; Yatabe M; Utsumi J; Mimaya J; Sekine I; Okada T; Smike S; Koizumi S; Imashuku S
Rinsho Ketsueki; 1984 Aug; 25(8):1209-17. PubMed ID: 6334758
[No Abstract] [Full Text] [Related]
15. [Use of monoclonal antibodies and molecular biology technics in the immunological classification of acute lymphoblastic leukemias].
Chen Z; Sigaux F
Pathol Biol (Paris); 1986 Jan; 34(1):5-7. PubMed ID: 2939390
[No Abstract] [Full Text] [Related]
16. Prognostic importance of immunologic markers in adult acute lymphoblastic leukemia.
Greaves MF; Lister TA
N Engl J Med; 1981 Jan; 304(2):119-20. PubMed ID: 6934374
[No Abstract] [Full Text] [Related]
17. Analysis of the clinical and biological significance of lymphoid phenotypes in acute leukemia.
Greaves MF
Cancer Res; 1981 Nov; 41(11 Pt 2):4752-66. PubMed ID: 7028250
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of cell surface markers in childhood acute lymphoblastic leukaemia.
Kumar S; Carr TF; Evans DI; Morris-Jones P; Hann IM
Clin Lab Haematol; 1979; 1(2):121-8. PubMed ID: 317037
[TBL] [Abstract][Full Text] [Related]
19. Use of monoclonal antibodies, morphology, and cytochemistry to probe the cellular heterogeneity of acute leukemia and lymphoma.
LeBien TW; McKenna RW; Abramson CS; Gajl-Peczalska KJ; Nesbit ME; Coccia PF; Bloomfield CD; Brunning RD; Kersey JH
Cancer Res; 1981 Nov; 41(11 Pt 2):4776-80. PubMed ID: 6945905
[TBL] [Abstract][Full Text] [Related]
20. Clinical usefulness of immunological marker analysis in adult patients with acute leukaemia.
Van 't Veer MB; Tetteroo PA; Von dem Borne KR; Engelfriet CP
Neth J Med; 1985; 28(3):124-7. PubMed ID: 3856755
[No Abstract] [Full Text] [Related]
[Next] [New Search]
